Featured Articles

91. Increasing Site & Patient Convenience For Oncology Clinical Trials 2/10/2021

    According to an ACSCAN report, out of all potential qualifying patients for a trial, only 44% of them have access to an available trial, only 27% are eligible for the trial, and only 8% are able to successfully enroll. Explore some of the obstacles facing oncology research as well as innovation opportunities that transform the way sites, sponsors, and CROs interact.

92. Decentralized Clinical Trials: Are They Here to Stay? 1/6/2021

    In 2020 the clinical trial industry adapted and responded in rapid fashion. Measures were taken to allow for continuity of studies, all while shortening timelines and ensuring safety and flexibility of care. This flexibility can be seen through trial decentralization – enabling care to be continued through varying methods, whether bringing care to the patient’s home, allowing patients to benefit from local labs or utilizing technology to complete trial requirements. This response by the industry was impressive and perhaps provides a glimpse into the future of clinical research. But what does the future look like?

93. Advancing Diversity In Clinical Trials: Building Awareness And Implementing Solutions To Enable Broad Participation In Research 12/14/2020

    The underrepresentation of certain populations in clinical research is a serious problem. However, sponsors and CROs are renewing their focus on diversity, and are looking for new ways to create awareness and remove obstacles through patient-centered solutions.

94. How Sponsors Can Overcome The Growing Challenges In Clinical Trial Budgeting And Negotiation 11/6/2020

    This paper seeks to explore the most crucial obstacles to successful budget design and negotiation in light of the current complexity experienced across the clinical trial universe. It highlights how technology can streamline these traditionally manual, time-consuming workflows, increase transparency and predictability, and deliver more current and accurate data for an optimized study start-up.

95. The Michael J. Fox Foundation For Parkinson's Research Works With Service Provider To Remove Reimbursement And Travel Obstacles For Clinical Study Participants 10/19/2020

    In 2010, MJFF launched a large-scale clinical study conducted at a network of clinical sites around the world focused on identifying and validating Parkinson’s disease biomarkers. The study realized it needed a new way to ensure that participants were remaining engaged throughout the long protocol and that the experience was as seamless as possible for both the volunteers and the site coordinators. They were able to source a solution to support patient-centricity, as well as study site efficiency.

96. The Ultimate Guide To Purchasing A Clinical Trial Study Participant Reimbursement System 10/16/2020

    This guide focuses on important areas to evaluate when vetting a platform for clinical research participant reimbursement. These crucial elements will help ensure the system you select improves the participant experience without increasing the burden on site staff.

97. How To Lose A Site In 10 Ways 10/16/2020

    In partnership with the Society for Clinical Research Sites, Greenphire has conducted a survey to hear directly from sites regarding Investigator Grant Payments. As such, we would like to share insights from the survey and suggestions for improving site satisfaction as it relates to invoicing and payment processes. Here is a list of 10 things sites say sponsors and/or CROs do that add stress to the relationship.

98. The Impact Of COVID-19 On Research Sites: Planning For The Road Back To Full Trial Operations 10/16/2020

    COVID-19 has had a dramatic impact on US clinical care, including how sites have worked to maintain research operations throughout the pandemic. The financial and logistical challenges faced by our site partners have been substantial, here is a recap of the adaptations they’ve made to manage through the current environment.

99. Clinical Trial Budget Challenges & Opportunities 6/3/2020

    Protocol complexities are becoming ever more complex, and with it, so has the clinical trial budgeting process. Plagued by multiple stakeholders using disconnected systems across the globe, delays and increased costs in study start up follow. Discover what sponsors need to consider in order to achieve first patient in as swiftly as possible.

100. Get Your Ducks In A Row 6/2/2020

     When developing a study budget, there are challenges for sites in addition to sponsors. Enable the negotiation process to be more effective for all stakeholders through an integrated workflow and up-to-date financial data. Listen to Catherine Click’s podcast with SCRS Talks, Society for Clinical Research Sites.